Healthcare

Viz.ai Broadens Healthcare System Integrations to Inform Critical Decisions at the Point of Care

Integration capabilities deliver real-time, disease-specific insights to healthcare providers to improve patient care and outcomesSAN FRANCISCO--(BUSINESS WIRE)--#ai--Viz.ai, the leader in…

8 months ago

KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat

– Full EAMS designation would allow treatment of patients with sebetralstat prior to receiving a Marketing Authorization from UK –CAMBRIDGE,…

8 months ago

Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by the Company's recent margin…

8 months ago

Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations

NORTHAMPTON, MA / ACCESSWIRE / March 12, 2024 / We're committed to increasing diverse representation in clinical trials, especially for…

8 months ago

Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences

ANN ARBOR, MI / ACCESSWIRE / March 12, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

8 months ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month ---- Study will evaluate the use…

8 months ago

Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold

– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming…

8 months ago

Roche Annual General Meeting 2024

All proposals of the Board of Directors approvedSeverin Schwan re-elected as Chairman of the Board of Directors; all other Board…

8 months ago

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

Company plans to hold a business update conference call in April DENVER, March 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical…

8 months ago

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

BERKELEY, Calif. and MAINZ, Germany, March 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

8 months ago